Trial no.:
|
PACTR201804003215168 |
Date of Approval:
|
19/03/2018 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
event related evoked potential versus clinical tests in assessment of subclinical cognitive impairment in chronic hepatitis c virus |
Official scientific title |
event related evoked potential versus clinical tests in assessment of subclinical cognitive impairement in chronic hepatitis c virus |
Brief summary describing the background
and objectives of the trial
|
chronic infection by hepatitis c virus causes impairment in neurocognitive function in up to 50% of patients which may not detected by clinical tests.
Objectives: early detection of neurocognitive impairment in chronic hepatitis c patients and investigating the cognitive function in hepatitis c virus patients by p300 and clinical trials. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
HCV- cognitive function,Mental and Behavioural Disorders,Nervous System Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Diagnosis / Prognosis |
Anticipated trial start date |
01/06/2017 |
Actual trial start date |
01/06/2017 |
Anticipated date of last follow up |
31/01/2018 |
Actual Last follow-up date |
31/01/2018 |
Anticipated target sample size (number of participants) |
90 |
Actual target sample size (number of participants) |
90 |
Recruitment status |
Completed |
Publication URL |
|
|